| Report ID | 277755 |
| Drug Identification Number | 02241799 |
| Brand name | PROCYTOX |
| Common or Proper name | PROCYTOX 1000MG |
| Company Name | BAXTER CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | CYCLOPHOSPHAMIDE |
| Strength(s) | 1000MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 2638B5033 1ea/pack |
| ATC code | L01AA |
| ATC description | ALKYLATINGAGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2026-02-10 |
| Actual start date | 2026-02-10 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Anticipated shortage |
| Updated date | 2026-02-23 |
| Company comments | Disruption of the manufacturing and Delay in shipping |
| Health Canada comments | |
| Tier 3 Status | Yes |
| Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
| Company contact information |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2026-02-23 | English | Compare |
| v2 | 2026-02-10 | French | Compare |
| v1 | 2026-02-10 | English | Compare |
Showing 1 to 3 of 3